524663
BIBCL
Start SIP
Invest Now
Start SIP in BIBCL
Performance
- Low
- ₹18
- High
- ₹19
- 52 Week Low
- ₹18
- 52 Week High
- ₹30
- Open Price₹19
- Previous Close₹18
- Volume20,666
- 50 DMA₹19.88
- 100 DMA₹20.59
- 200 DMA₹21.80
Investment Returns
- Over 1 Month -2.54%
- Over 3 Month -11.19%
- Over 6 Month -21.12%
- Over 1 Year -26.89%
Smart Investing Starts Here Start SIP with Bharat Immunological & Biologicals Corporation for Steady Growth!
Bharat Immunological & Biologicals Corporation Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- -4.3
- PEG Ratio
- 0
- Market Cap Cr
- 80
- P/B Ratio
- 0.9
- Average True Range
- 0.84
- EPS
- -
- Dividend Yield
- 0
- MACD Signal
- -0.16
- RSI
- 37.86
- MFI
- 13.17
Bharat Immunological & Biologicals Corporation Financials
Bharat Immunological & Biologicals Corporation Technicals
EMA & SMA
Current Price
₹18.41
+
0.25
(1.38%)
- Bearish Moving Average 16
- Bullish Moving Average 0
- 20 Day
- ₹19.41
- 50 Day
- ₹19.88
- 100 Day
- ₹20.59
- 200 Day
- ₹21.80
Resistance and Support
18.45
- R3 19.23
- R2 18.98
- R1 18.70
- S1 18.17
- S2 17.92
- S3 17.64
Bharat Immunological & Biologicals Corporation Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2024-08-16 | General Purpose. | |
| 2024-03-08 | Others | General Purpose |
| 2023-10-31 | Quarterly Results | |
| 2023-04-24 | Audited Results | |
| 2023-02-09 | Quarterly Results |
Bharat Immunological & Biologicals Corporation F&O
About Bharat Immunological & Biologicals Corporation
- NSE Symbol
- BIBCL
- BSE Symbol
- 524663
- Managing Director
- Dr. Sanjay Kumar Mishra
- ISIN
- INE994B01014
Similar Stocks to Bharat Immunological & Biologicals Corporation
Bharat Immunological & Biologicals Corporation FAQs
Bharat Immunological & Biologicals Corporation share price is ₹18 As on 15 January, 2026 | 23:29
The Market Cap of Bharat Immunological & Biologicals Corporation is ₹79.5 Cr As on 15 January, 2026 | 23:29
The P/E ratio of Bharat Immunological & Biologicals Corporation is -4.3 As on 15 January, 2026 | 23:29
The PB ratio of Bharat Immunological & Biologicals Corporation is 0.9 As on 15 January, 2026 | 23:29
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.